- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07609173
Immediate Effects of Shock Wave Therapy With Stretching or Isometric Contraction on Upper Trapezius (rESWT)
The Immediate Effects of Simultaneous Application of Radial Extracorporeal Shock Wave Therapy and Stretching or Isometric Contraction on Muscle Tone, Stiffness, Thickness, Pressure Pain Threshold, and Grip Strength of the Upper Trapezius
Excessive use of smart devices and prolonged sitting posture in modern daily life can lead to potential hypertonicity and functional impairment of the upper trapezius even in healthy individuals. Such conditions may cause functional changes and discomfort before the onset of pain, and early intervention may help prevent the progression to musculoskeletal disorders. Therefore, this study aims to investigate the immediate effects of radial extracorporeal shock wave therapy (rESWT) applied simultaneously with stretching or isometric contraction on muscle tone, stiffness, thickness, pressure pain threshold, and grip strength of the upper trapezius in healthy adults.
Participants will be divided into two groups : rESWT + stretching and rESWT + isometric contraction. Immediate changes in the upper trapezius will be compared before and after the interventions. rESWT will be applied to the upper trapezius with 1.0 bar pressure, 10 Hz frequency, and 1000 shocks.
Visão geral do estudo
Status
Condições
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Gwangju, Coréia do Sul, 62287
- 73, Bungmun-daero 419beon-gil, Gwangju health university
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Individuals with no history of neck or shoulder pain in the past 6 months
- Individuals with no history of upper limb musculoskeletal disorders
- Individuals with a pressure pain threshold (PPT) of the upper trapezius ≥ 263 kPa
Exclusion Criteria:
- Individuals with a history of neurological or orthopedic disorders
- Individuals taking medications that may affect ESWT response
- Individuals with local skin conditions, including ulcers or open wounds
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: experimental 1 group
Radial Extracorporeal Shock Wave Therapy and Stretching
|
Participants will sit on a chair and receive rESWT with gel applied to the upper trapezius. A 20 mm rESWT applicator angled at 90° will be applied to the muscle belly and the musculotendinous junction. The intensity will be set at 1.0 bar pressure, 10 Hz frequency, with 1000 shocks. When rESWT is applied to the upper trapezius, participants will sit on a chair and repeatedly bend the neck diagonally to stretch the muscle, then return to the neutral position. |
|
Comparador Ativo: experimental 2 group
Radial Extracorporeal Shock Wave Therapy and Isometric Contraction
|
Participants will sit on a chair and receive rESWT with gel applied to the upper trapezius. A 20 mm rESWT applicator angled at 90° will be applied to the muscle belly and the musculotendinous junction. The intensity will be set at 1.0 bar pressure, 10 Hz frequency, with 1000 shocks. When rESWT is applied to the upper trapezius, participants will sit on a chair and maintain a shoulder elevation posture during the intervention. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Muscle Tone
Prazo: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
Upper trapezius muscle stiffness will be assessed as dynamic stiffness (N/m) using the MyotonPRO device (Myoton AS, Tallinn, Estonia).
The probe will be positioned perpendicular to the skin over the belly of the upper trapezius muscle.
After a pre-load of approximately 0.18 N, 10 mechanical impulses of approximately 0.4 N at 1 Hz will be delivered.
Measurements will be repeated 3 times, and the mean value will be used for analysis.
Change from baseline will be calculated as the immediate post-intervention value minus the baseline value.
|
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
|
Muscle Stiffnes
Prazo: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
Upper trapezius muscle stiffness will be assessed as dynamic stiffness (N/m) using the MyotonPRO device (Myoton AS, Tallinn, Estonia).
The probe will be positioned perpendicular to the skin over the belly of the upper trapezius muscle.
After a pre-load of approximately 0.18 N, 10 mechanical impulses of approximately 0.4 N at 1 Hz will be delivered.
Measurements will be repeated 3 times, and the mean value will be used for analysis.
Change from baseline will be calculated as the immediate post-intervention value minus the baseline value.
|
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
|
Muscle Thickness
Prazo: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
The probe of the ultrasound imaging device is placed perpendicular to the target area without applying any pressure after applying a water-based transmission gel, in order to measure muscle thickness.
Then, using a 2.5 MHz ultrasound, strong echoes at tissue interfaces are focused, and the distance between the focused points is converted into millimeters to determine tissue thickness.
|
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
|
Grip Strength
Prazo: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
Grip strength is measured using a wireless dynamometer.
The participant holds the dynamometer with the arm relaxed, the elbow flexed at 90°, the arm slightly away from the torso, and the wrist in a neutral position.
Following the researcher's instructions, the participant exerts maximum force.
The measurement is repeated three times, and the average value is recorded.
|
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
|
Pressure Pain
Prazo: Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
The participant sits upright with the back supported by a wall or chair and feet flat on the floor.
A pressure algometer with a 1 cm² rubber tip is placed perpendicular to the same muscle belly measured by the Myoton PRO.
The researcher applies gradual pressure at a constant rate of 0.5 kg/cm²/s until the participant reports pain, and the value at the point of reported pain is recorded.
The measurement is repeated twice, and the average value is used.
|
Post-intervention measurement is conducted immediately after the intervention to assess immediate effects.
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- SYU 2025-06-024-001
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .